1. Stocks
  2. Oncocyte Corporation
  3. Swot
swot-logo

Oncocyte Corporation SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Oncocyte Corporation has 13 Strengths, 7 Weaknesses, 0 Opportunities and 4 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Increasing Revenue every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Stock gained more than 20% in one month

Stock with Low PE (PE < = 10)

Stocks Outperforming their Industry Price Change in the Quarter

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Top Losers

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Declining profits every quarter for the past 2 quarters

Top Losers

Stocks rising sharply on very low month volumes

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Institutions decreased their shareholding last quarter

Promoters increasing shareholding QoQ

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks